Birmingham, AL, United States of America

Philip Chen

This inventor holds 1 USPTO granted patent. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Chen. Retrieved from https://idiyas.com/inventor/philip-chen-s7th4ewt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Philip Chen

Introduction

Philip Chen is a notable inventor based in Birmingham, Alabama. He has made significant contributions to the field of medical research, particularly in cancer treatment. His work focuses on the use of phospholipase C inhibitors to combat tumor progression and metastasis.

Latest Patents

Philip Chen holds a patent for his invention titled "Uses of phospholipase C inhibitors." This patent outlines a method for inhibiting tumor progression in individuals requiring treatment. The method involves administering a pharmacologically effective dose of a phospholipase C inhibitor. Additionally, the patent provides a method for inhibiting metastasis in similar patients. It also includes pharmaceutical compositions that combine phospholipase C inhibitors with antineoplastic agents and pharmaceutically acceptable carriers.

Career Highlights

Philip Chen is associated with the UAB Research Foundation, where he conducts his research and development. His work has the potential to significantly impact cancer therapies and improve patient outcomes.

Collaborations

Some of his notable coworkers include Timothy Turner and Alan Wells, who contribute to the collaborative research efforts at the UAB Research Foundation.

Conclusion

Philip Chen's innovative work in the field of cancer treatment through the use of phospholipase C inhibitors showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer and highlight the importance of research in developing effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…